₹380.4
▼ -4.3 -1.12%
16 Jun 2026
BSE Listed · Pharmaceuticals
FDC Ltd. (531599)
Volume: 5,183Avg Vol 1W: 13,549Avg Vol 1M: 25,74552W Range:₹312.95₹527.8
Key Ratios
Updated 2h agoMarket Cap₹6,315 Cr
Current Price₹380.4
Previous Close₹384.7
High / Low (52w)₹527.8 / ₹312.95
Volume5,183
Avg Vol (1W)13,549
Avg Vol (1M)25,745
Stock P/E24.06
Book Value₹152.65
Dividend Yield1.29%
ROE11.32%
ROA9.64%
Revenue (TTM)—
Revenue Growth8.5%
Profit Margin12.96%
Total Debt₹10,97,000 Cr
Shares Outstanding16 Cr
Face Value₹1
EPS (TTM)₹6.35
P/B2.49
Debt / Equity0.01
50 DMA₹371.5
200 DMA₹401.78
Day change-1.12%
Price Chart
₹384.6▼ 18.71% · 1Y
2025-06-172026-06-16
20-day avg volume: 26K shares
Pros
- Company is almost debt-free.
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sept 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sept 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sept 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sept 2020 | Jun 2020 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹585 Cr | ₹465 Cr | ₹473 Cr | ₹648 Cr | ₹492 Cr | ₹464 Cr | ₹514 Cr | ₹638 Cr | ₹462 Cr | ₹458 Cr | ₹486 Cr | ₹536 Cr | ₹435 Cr | ₹409 Cr | ₹445 Cr | ₹495 Cr | ₹341 Cr | ₹342 Cr | ₹398 Cr | ₹447 Cr | ₹313 Cr | ₹340 Cr | ₹371 Cr | ₹308 Cr | ₹333 Cr |
| EBITDA | ₹142 Cr | ₹58 Cr | ₹39 Cr | ₹161 Cr | ₹55 Cr | ₹52 Cr | ₹91 Cr | ₹164 Cr | ₹66 Cr | ₹99 Cr | ₹94 Cr | ₹142 Cr | ₹46 Cr | ₹58 Cr | ₹70 Cr | ₹88 Cr | ₹20 Cr | ₹52 Cr | ₹92 Cr | ₹129 Cr | ₹57 Cr | ₹100 Cr | ₹115 Cr | ₹122 Cr | ₹58 Cr |
| Net Profit | ₹103 Cr | ₹28 Cr | ₹28 Cr | ₹121 Cr | ₹39 Cr | ₹37 Cr | ₹72 Cr | ₹119 Cr | ₹46 Cr | ₹79 Cr | ₹70 Cr | ₹110 Cr | ₹31 Cr | ₹41 Cr | ₹52 Cr | ₹71 Cr | ₹10 Cr | ₹36 Cr | ₹72 Cr | ₹98 Cr | ₹47 Cr | ₹75 Cr | ₹88 Cr | ₹92 Cr | ₹55 Cr |
| EPS | 6.35 | 1.74 | 1.75 | 7.45 | 2.38 | 2.28 | 4.43 | 7.31 | 2.84 | 4.86 | 4.22 | 6.62 | 1.85 | 2.45 | 3.1 | 4.23 | 0.62 | 2.11 | 4.28 | 5.8 | 2.77 | 4.45 | 5.15 | 5.36 | 3.22 |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Revenue | ₹2,199 Cr | ₹2,045 Cr | ₹1,834 Cr | ₹1,604 Cr | ₹1,430 Cr | ₹1,413 Cr |
| EBITDA | ₹362 Cr | ₹400 Cr | ₹262 Cr | ₹292 Cr | ₹393 Cr | ₹324 Cr |
| Net Profit | ₹267 Cr | ₹305 Cr | ₹194 Cr | ₹216 Cr | ₹301 Cr | ₹240 Cr |
| EPS | 16.39 | 18.58 | 11.66 | 12.81 | 17.73 | 13.94 |
Balance Sheet
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Total Assets | ₹2,714 Cr | ₹2,468 Cr | ₹2,343 Cr | ₹2,270 Cr | ₹1,956 Cr | ₹1,813 Cr |
| Total Liabilities | ₹433 Cr | ₹371 Cr | ₹362 Cr | ₹314 Cr | ₹222 Cr | ₹266 Cr |
| Equity | ₹2,281 Cr | ₹2,097 Cr | ₹1,981 Cr | ₹1,956 Cr | ₹1,734 Cr | ₹1,547 Cr |
| Total Debt | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
Cash Flow
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Operating | ₹420 Cr | ₹325 Cr | ₹232 Cr | ₹241 Cr | ₹302 Cr | ₹335 Cr |
| Investing | ₹-200 Cr | ₹-17 Cr | ₹11 Cr | ₹-145 Cr | ₹-77 Cr | ₹-98 Cr |
| Financing | ₹-92 Cr | ₹-202 Cr | ₹-180 Cr | ₹-10 Cr | ₹-129 Cr | ₹-142 Cr |
| Free Cash Flow | ₹420 Cr | ₹325 Cr | ₹232 Cr | ₹241 Cr | ₹302 Cr | ₹335 Cr |
Shareholding
Promoter 69.66% Institutions 8.69% Public 21.65%
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search